We're Hopeful That Lin BioScience (GTSM:6696) Will Use Its Cash Wisely
Just because a business does not make any money, does not mean that the stock will go down. For example, Lin BioScience...
Has the Taiwanese Healthcare Sector valuation changed over the past few years?
|Wed, 26 Jan 2022||NT$1.1t||NT$202.1b||NT$14.1b||21.5x|
|Fri, 24 Dec 2021||NT$1.2t||NT$202.1b||NT$14.1b||21.9x|
|Sun, 21 Nov 2021||NT$1.1t||NT$202.4b||NT$13.3b||20.4x|
|Tue, 19 Oct 2021||NT$1.0t||NT$197.1b||NT$14.2b||20.5x|
|Thu, 16 Sep 2021||NT$1.0t||NT$197.1b||NT$14.2b||21.5x|
|Sat, 14 Aug 2021||NT$1.1t||NT$197.0b||NT$14.1b||22x|
|Wed, 09 Jun 2021||NT$1.1t||NT$191.4b||NT$14.8b||20.9x|
|Tue, 02 Mar 2021||NT$940.9b||NT$186.1b||NT$9.7b||19.1x|
|Fri, 04 Dec 2020||NT$923.3b||NT$179.1b||NT$4.8b||20.9x|
|Mon, 07 Sep 2020||NT$955.7b||NT$174.2b||NT$2.1b||22.7x|
|Sun, 31 May 2020||NT$789.5b||NT$171.3b||-NT$2,449,886,500.00||23.4x|
|Wed, 04 Mar 2020||NT$637.6b||NT$170.7b||-NT$2,703,537,000.00||21x|
|Sat, 07 Dec 2019||NT$664.2b||NT$167.5b||NT$1.6b||19.6x|
|Tue, 10 Sep 2019||NT$637.2b||NT$169.8b||NT$3.1b||19.6x|
|Mon, 03 Jun 2019||NT$638.8b||NT$173.0b||NT$3.9b||20.8x|
|Thu, 07 Mar 2019||NT$673.9b||NT$174.5b||NT$5.3b||21.5x|
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 21.0x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 39% per year over the last three years, and revenues for these companies have grown 5.0% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the Taiwanese Healthcare sector?
Industry PE: Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 23.5x. This is likely because analysts are expecting annual earnings growth of 218%, which is higher than its past year's earnings growth of 19% per year. Meanwhile, investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 20.1x.
Forecasted Growth: Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 218% over the next 5 years. This is better than it's past earnings growth rate of 19% per year. Meanwhile, the Medical Equipment industry is expected to see its earnings grow by 9.1% per year over the next few years.
Which companies have driven the market over the last 7 days?
Medigen Vaccine Biologics
Panion & Bf Biotech